These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 520660)

  • 1. The treatment of atrophic vaginal conditions with Ortho-Gynest: a pilot study.
    Karoussos KE; Studer S; Wyss HJ
    J Int Med Res; 1979; 7(6):569-72. PubMed ID: 520660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local therapy of atrophic vaginal conditions with oestriol suppositories.
    Michalas S; Papandrikos A; Koutselini E; Tzingounis V
    J Int Med Res; 1980; 8(5):358-60. PubMed ID: 6998796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, cytological and biological study of the intra-vaginal administration of oestriol (Ortho-Gynest) in post-menopausal patients.
    Wesel S; Etienne J; Lestienne MC
    Maturitas; 1981 Dec; 3(3-4):271-7. PubMed ID: 7334936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practical observations on the use of the Ortho-Gynest vaginal globules from the firm of Cillag--Switzerland].
    Milchev N; Grozdanov G; Krumov G
    Akush Ginekol (Sofiia); 1993; 32(2):46. PubMed ID: 8010406
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.
    Foidart JM; Vervliet J; Buytaert P
    Maturitas; 1991 Jun; 13(2):99-107. PubMed ID: 1921739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-acting oestriol on the vaginal cytology of postmenopausal women.
    Purola E; Vartiainen E
    Ann Chir Gynaecol; 1977; 66(4):216-8. PubMed ID: 907314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
    Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
    Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience].
    Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E
    Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects.
    Kicovic PM; Cortes-Prieto J; Milojević S; Haspels AA; Aljinovic A
    Maturitas; 1980 Dec; 2(4):275-82. PubMed ID: 6785553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
    Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
    Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
    Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of estriol and equine conjugated estrogens on the uterus and the vagina.
    Phillips A; Hahn DW; McGuire JL
    Maturitas; 1984 Mar; 5(3):147-52. PubMed ID: 6328221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravaginal treatment of colpitis maculosa with an oestriol-containing vaginal cream (author's transl)].
    Schröck A; Kofler K; Baumgarten K; Endl J; Schmidt J; Tatschl S
    Wien Klin Wochenschr; 1981 Dec; 93(23):713-6. PubMed ID: 7342467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
    Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
    Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.